MiNK Therapeutics, Inc.INKTNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank73
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P73
Within normal range
vs 2Y Ago
1.1x
Modest growth
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q3 202518.94%
Q2 2025-45.62%
Q1 2025-14.35%
Q4 2024-30.01%
Q3 202441.29%
Q2 202424.24%
Q1 202430.37%
Q4 2023-5.29%
Q3 202317.65%
Q2 2023-8.36%
Q1 202325.79%
Q4 20221.23%
Q3 2022-3.75%
Q2 2022-4.40%
Q1 2022-16.81%
Q4 2021-52.16%
Q3 202126.07%
Q2 2021-51.99%
Q1 2021-142.22%
Q4 202074.27%
Q3 2020-64.82%
Q2 20200.00%
Q1 20200.00%